Using dye imaging to diagnose severe flesh-eating infections
Part of Bones, joints & muscles clinical trials.
This trial tests a new way to quickly diagnose necrotizing soft tissue infections (NSTIs, also called flesh-eating infections) using a safe dye and a camera. If you are being checked for a possible NSTI, this could help doctors decide faster whether you have it and need treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- Your doctor thinks you may have a necrotizing soft tissue infection and has admitted you to the hospital, ordered a biopsy, or scheduled surgery for it
- You can understand and sign a consent form
- You have not had an allergic reaction to indocyanine green (ICG) dye or iodine in the past
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if injecting a special dye (ICG) during surgery can help doctors see blood flow and infection in open fractures or infected bone areas. The dye glows under a special camera, which may guide better treatment decisions.
This trial tests a dye called indocyanine green (ICG) that makes cancer cells glow under a special camera during surgery. It may help doctors remove more cancer and leave healthy tissue alone.
This trial tests whether a special dye (ICG) seen during your surgery can help doctors better identify the edges of a tumor in bone or soft tissue. It may help ensure as much of the tumor is removed as safely as possible.
This early (Phase 1) study tests whether a glowing dye called indocyanine green helps surgeons better see nervous system tumor tissue during an operation, with the goal of lowering the chance of tumor coming back locally. It’s for adults whose tumor is expected to be removable and at risk for local recurrence.
This study uses a special dye that makes tumors glow during surgery, helping your surgeon see exactly what to remove and what to leave. It aims to make surgery more precise and safer for people with bone or soft tissue tumors.
This trial compares two dyes used during stomach or intestine surgery to see which helps surgeons see the blood flow better. It may help decide which dye works best for safe reconnections.
Hear when a new Necrotizing Fascitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.